New Jersey
How Arato v. Avedon applies in New Jersey: state-specific rules, key cases, and bar exam notes for Torts (Medical Malpractice – Informed Consent).
New Jersey applies the doctrine of informed consent similarly to the principles established in Arato v. Avedon, which emphasizes a healthcare provider's duty to disclose pertinent risks associated with treatment. Informed consent in New Jersey mandates that patients are made aware of the necessary information to make an educated decision regarding their medical treatment.
In New Jersey, the rule requires healthcare providers to inform patients of the risks, benefits, and alternatives to a proposed treatment in order to obtain informed consent, a principle fortified by the 'reasonable patient' standard.
The New Jersey Supreme Court held that the physician's duty to inform patients about treatment risks is non-delegable and must be fulfilled by the physician themselves.
The court clarified that for informed consent claims in New Jersey, a failure to inform must be shown to have affected the patient's decision-making process.
This case reinforced that a physician must disclose any information that a reasonable patient would consider significant when making the decision regarding medical treatment.
New Jersey's informed consent requirements are more stringent compared to the federal standard, which typically allows for broader discretion by physicians regarding disclosures. The New Jersey approach focuses on a subjective patient standard, emphasizing what a reasonable patient would want to know, while federal standards may allow for less transparency.
The principles from Arato v. Avedon and related informed consent doctrines are frequently tested in New Jersey bar exams, emphasizing medical malpractice and the obligations of physicians regarding patient disclosures.